Annual CFO
-$6.81 M
+$4.38 M+39.15%
31 December 2023
Summary:
Adial Pharmaceuticals annual cash flow from operations is currently -$6.81 million, with the most recent change of +$4.38 million (+39.15%) on 31 December 2023. During the last 3 years, it has risen by +$826.40 thousand (+10.83%). ADIL annual CFO is now -2380.61% below its all-time high of -$274.40 thousand, reached on 31 December 2016.ADIL Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$1.69 M
+$454.10 K+21.14%
30 September 2024
Summary:
Adial Pharmaceuticals quarterly cash flow from operations is currently -$1.69 million, with the most recent change of +$454.10 thousand (+21.14%) on 30 September 2024. Over the past year, it has dropped by -$303.10 thousand (-21.79%). ADIL quarterly CFO is now -1883.72% below its all-time high of -$85.40 thousand, reached on 31 March 2017.ADIL Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$6.69 M
-$303.10 K-4.74%
30 September 2024
Summary:
Adial Pharmaceuticals TTM cash flow from operations is currently -$6.69 million, with the most recent change of -$303.10 thousand (-4.74%) on 30 September 2024. Over the past year, it has increased by +$644.00 thousand (+8.78%). ADIL TTM CFO is now -7735.01% below its all-time high of -$85.40 thousand, reached on 31 March 2017.ADIL TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADIL Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +39.1% | -21.8% | +8.8% |
| 3 y3 years | +10.8% | +52.0% | +45.1% |
| 5 y5 years | -172.4% | +1.8% | -17.6% |
ADIL Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +43.0% | -38.6% | +52.1% | -9.1% | +45.1% |
| 5 y | 5 years | -172.4% | +43.0% | -72.0% | +52.1% | -17.6% | +45.1% |
| alltime | all time | -2380.6% | +43.0% | -1883.7% | +52.1% | -7735.0% | +45.1% |
Adial Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.69 M(-21.1%) | -$6.69 M(+4.7%) |
| June 2024 | - | -$2.15 M(+32.1%) | -$6.39 M(+4.1%) |
| Mar 2024 | - | -$1.63 M(+33.0%) | -$6.13 M(-9.9%) |
| Dec 2023 | -$6.81 M(-39.1%) | -$1.22 M(-12.1%) | -$6.81 M(-7.2%) |
| Sept 2023 | - | -$1.39 M(-26.6%) | -$7.34 M(-21.5%) |
| June 2023 | - | -$1.89 M(-17.6%) | -$9.35 M(-14.9%) |
| Mar 2023 | - | -$2.30 M(+31.3%) | -$10.99 M(-1.8%) |
| Dec 2022 | -$11.19 M(-6.4%) | -$1.75 M(-48.6%) | -$11.19 M(-5.3%) |
| Sept 2022 | - | -$3.40 M(-3.7%) | -$11.81 M(-1.1%) |
| June 2022 | - | -$3.53 M(+41.6%) | -$11.93 M(+2.9%) |
| Mar 2022 | - | -$2.50 M(+5.2%) | -$11.60 M(-2.9%) |
| Dec 2021 | -$11.95 M(+56.5%) | -$2.37 M(-32.8%) | -$11.95 M(-2.0%) |
| Sept 2021 | - | -$3.53 M(+10.2%) | -$12.19 M(+12.2%) |
| June 2021 | - | -$3.20 M(+12.7%) | -$10.87 M(+25.6%) |
| Mar 2021 | - | -$2.84 M(+8.8%) | -$8.65 M(+13.3%) |
| Dec 2020 | -$7.63 M | -$2.61 M(+18.4%) | -$7.63 M(+12.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$2.21 M(+124.2%) | -$6.77 M(+7.7%) |
| June 2020 | - | -$985.20 K(-46.0%) | -$6.29 M(-2.4%) |
| Mar 2020 | - | -$1.83 M(+4.1%) | -$6.44 M(+1.6%) |
| Dec 2019 | -$6.34 M(+153.7%) | -$1.75 M(+1.6%) | -$6.34 M(+11.4%) |
| Sept 2019 | - | -$1.72 M(+51.2%) | -$5.69 M(+14.8%) |
| June 2019 | - | -$1.14 M(-33.8%) | -$4.96 M(+23.8%) |
| Mar 2019 | - | -$1.72 M(+55.9%) | -$4.01 M(+60.3%) |
| Dec 2018 | -$2.50 M(+404.8%) | -$1.10 M(+11.4%) | -$2.50 M(+64.7%) |
| Sept 2018 | - | -$991.30 K(+424.8%) | -$1.52 M(+129.1%) |
| June 2018 | - | -$188.90 K(-11.9%) | -$662.10 K(+6.1%) |
| Mar 2018 | - | -$214.30 K(+75.5%) | -$623.80 K(+26.0%) |
| Dec 2017 | -$494.90 K(+80.4%) | -$122.10 K(-10.7%) | -$494.90 K(+32.8%) |
| Sept 2017 | - | -$136.80 K(-9.2%) | -$372.80 K(+58.0%) |
| June 2017 | - | -$150.60 K(+76.3%) | -$236.00 K(+176.3%) |
| Mar 2017 | - | -$85.40 K | -$85.40 K |
| Dec 2016 | -$274.40 K(-41.0%) | - | - |
| Dec 2015 | -$465.20 K | - | - |
FAQ
- What is Adial Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals annual CFO year-on-year change?
- What is Adial Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals quarterly CFO year-on-year change?
- What is Adial Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals TTM CFO year-on-year change?
What is Adial Pharmaceuticals annual cash flow from operations?
The current annual CFO of ADIL is -$6.81 M
What is the all time high annual CFO for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high annual cash flow from operations is -$274.40 K
What is Adial Pharmaceuticals annual CFO year-on-year change?
Over the past year, ADIL annual cash flow from operations has changed by +$4.38 M (+39.15%)
What is Adial Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of ADIL is -$1.69 M
What is the all time high quarterly CFO for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high quarterly cash flow from operations is -$85.40 K
What is Adial Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, ADIL quarterly cash flow from operations has changed by -$303.10 K (-21.79%)
What is Adial Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of ADIL is -$6.69 M
What is the all time high TTM CFO for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high TTM cash flow from operations is -$85.40 K
What is Adial Pharmaceuticals TTM CFO year-on-year change?
Over the past year, ADIL TTM cash flow from operations has changed by +$644.00 K (+8.78%)